Abstract:Background: Cytotoxic T lymphocytes take on a leading role in many immune-related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8+ T cells need to adapt their metabolism and effector function to the harsh and nutrient-deprived conditions of the disease-associated microenvironment. Methods: We used an in vitro starvation as well as rapamycin treatment protocol mimicking nutrient deprivation to generate CD8Low versus CD8High T cells and performed FACS-Sorting followed by transcriptomic profiling of the cytotoxic T cell subsets. Prominent markers identified in the CD8Low versus the CD8High T cells were then used to investigate the presence of these cell subsets in immune-related human diseases. Employing cancer tissue microarrays and PhenOptics multispectral imaging as well as flow cytometry, we studied these CD8+ T cell subsets in cancer and relapsing-remitting multiple sclerosis patients. Results: Starvation induced a decreased expression of CD8, yielding a CD8Low T cell subpopulation with an altered transcriptomic signature and reduced effector function. CD8Low T cell showed enhanced ST2L and IL6ST (CD130) expression compared to CD8High T cells which expressed elevated KLRD1 (CD94) and granzyme B levels within the tumour microenvironment (TME). Spatial analysis revealed the presence of CD8High T cells in close proximity to tumour cells, while the CD8Low T cells resided at the tumour boundaries. Importantly, the number of tumour-infiltrating CD8Low T lymphocytes correlated with a poor prognosis as well as with enhanced cancer progression in human mammary carcinoma. We also found a reduced frequency of CD8Low T lymphocytes in a cohort of relapse (disease active) multiple sclerosis patients compared to healthy subjects during immune cell starvation in vitro. Conclusions: In summary, our data show that functionally distinct cytotoxic T lymphocytes can be identified based on their expression of CD8. Indicating a more general role in CD8 T cell immunity, these cells may play opposing roles in the TME, and also in the pathophysiology of autoimmune diseases such as multiple sclerosis.

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

CD8+ T cell tolerance: It doesn't translate

Inhibition of follicular T-helper cells by CD8 + regulatory T cells is essential for self tolerance

T Cells Specific for Post-Translational Modifications Escape Intrathymic Tolerance Induction

Tumor-Reactive CD8+ T Cells Enter a TCF1+PD-1- Dysfunctional State

CD8+ T cell differentiation and dysfunction in cancer

Deconstructing CTL-mediated autoimmunity through weak TCR-cross-reactivity towards highly abundant self-antigen

A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo

Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants

A lymphoid tissue chemokine checkpoint prevents loss of CD8+ T cell functionality

Cellular and molecular signaling towards T cell immunological self-tolerance

A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet

CD8+ T cell states in human cancer: insights from single-cell analysis

Control of CD8 T cell proliferation and terminal differentiation by active STAT5 and CDKN2A/CDKN2B

Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

CD8+ T Cell Exhaustion in Cancer

Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

Heterogeneity in allospecific T cell function in transplant tolerant hosts determines susceptibility to rejection following infection

PD-1 controls differentiation, survival, and TCR affinity evolution of stem-like CD8+ T cells

Characterization of an Expanded IL-10-Producing-Suppressive T Cell Population Associated with Immune Tolerance